Open-access-articles-on-structure-based-drug-discovery|OMICS International|Drug Designing: Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Articles On Structure Based Drug Discovery

Drug designing is the approach of finding drugs based on their targets and typically a drug target is a key molecule involved in a particular metabolism or signaling Pathway that is specific to a disease condition or Pathology or to be infectivity or survival of a microbial Pathogen. Some approaches attempt to stop the functioning of the pathway in the diseased state by causing a key molecule to stop functioning. However these drugs would also have to be designed in such a way as not to affect any other important molecules that may be similar in appearance to the key molecules. Vs K.Ramanathan, Structure Based Drug Designing for Diabetes Mellitus. The journal focuses on all fields of drug design including drug discovery, drug design by rational approach, target-based design, drug synthesis, drug metabolism, structure-based drug design, molecular modeling, ligand-based interaction, development of the generic drug, in silico chemoinformatics and bioinformatics technologies, receptor agonist/antagonist, protease substrate/inhibitor, peptidomimetic.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on February, 2021